Octarine Bio engineers microbial systems via precision fermentation to create PurePalette, a natural pigment platform that can deliver the full colour spectrum through a single production process. The pigments are designed to integrate seamlessly with existing textile dyeing workflows while offering superior colour strength, performance and stability compared with fossil-based dyes. Beyond textiles, the company is exploring applications in food & beverage and cosmetics, emphasising a significantly lower environmental footprint across sectors. With the latest capital, Octarine will scale industrial-level production of its first three flagship colours and execute commercial partnerships already in place. The firm also plans to validate PurePalette at industrial scale and broaden product development into additional industries. Including the new funding, Octarine’s Series A totals €12.8 million, reflecting continued investor confidence. Key backers now include The Footprint Firm, Edaphon, Unconventional Ventures, DSM-Firmenich Ventures, Oskare Capital, several business angels, and noted Danish biotech veterans Per Falholt and Steen Riisgaard.

Total raised

$14M

Funding rounds

5

Latest round

Series A

Latest activity

Jan 2026